C07C 259/12
Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being
Official title: with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. N-hydroxyamidines
C07C259/12 (Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being) appears on 205 US grants and 150 published applications in this corpus.
Search patents in C07C- Granted patents
- 205
- Published applications
- 150
- Assignees
- 116
- Inventors
- 692
- Latest grant
- 7 Apr 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 4 | 0 |
| 1977 | 6 | 0 |
| 1978 | 3 | 0 |
| 1979 | 5 | 0 |
| 1980 | 6 | 0 |
| 1981 | 3 | 0 |
| 1982 | 4 | 0 |
| 1983 | 3 | 0 |
| 1984 | 0 | 0 |
| 1985 | 1 | 0 |
| 1986 | 2 | 0 |
| 1987 | 3 | 0 |
| 1988 | 1 | 0 |
| 1989 | 1 | 0 |
| 1990 | 4 | 0 |
| 1991 | 2 | 0 |
| 1992 | 1 | 0 |
| 1993 | 2 | 0 |
| 1994 | 1 | 0 |
| 1995 | 4 | 0 |
| 1996 | 4 | 0 |
| 1997 | 4 | 0 |
| 1998 | 7 | 0 |
| 1999 | 7 | 0 |
| 2000 | 7 | 0 |
| 2001 | 11 | 5 |
| 2002 | 11 | 8 |
| 2003 | 6 | 8 |
| 2004 | 8 | 11 |
| 2005 | 5 | 5 |
| 2006 | 7 | 10 |
| 2007 | 5 | 8 |
| 2008 | 2 | 5 |
| 2009 | 5 | 10 |
| 2010 | 5 | 7 |
| 2011 | 4 | 6 |
| 2012 | 6 | 7 |
| 2013 | 6 | 6 |
| 2014 | 7 | 7 |
| 2015 | 4 | 4 |
| 2016 | 4 | 3 |
| 2017 | 5 | 7 |
| 2018 | 2 | 2 |
| 2019 | 2 | 5 |
| 2020 | 3 | 2 |
| 2021 | 2 | 4 |
| 2022 | 2 | 4 |
| 2023 | 1 | 4 |
| 2024 | 1 | 4 |
| 2025 | 5 | 5 |
| 2026 | 1 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
- C07C 259/18Having carbon atoms of hydroxamidine groups bound to carbon atoms of six-membered123
- C07C 259/14Having carbon atoms of hydroxamidine groups bound to hydrogen atoms or to73
- C07C 259/20With at least one nitrogen atom of hydroxamidine groups bound to another10
- C07C 259/16Having carbon atoms of hydroxamidine groups bound to carbon atoms of rings8
Recent patents
- Amidines and amidine analogs for the treatment of bacterial infections and potentiation antibiotics7 Apr 2026US 12,595,251 B2Georgia State University Research Foundation, Inc.
- Preparation of substituted 4-(N′-hydroxycarbamimidoyl)benzoic acids2 Dec 2025US 12,486,221 B2BASF SE
- Organic compound (oxime) to combat chemical warfare agents21 Oct 2025US 12,448,356 B2Prepaire Labs Limited
- Class A GPCR-binding compound modifier15 Apr 2025US 12,275,687 B2Riken
- Methods for preparing dihydroxyammonium 5,5′-bistetrazole-1,1′diolate25 Mar 2025US 12,258,322 B2Agency for Defense Development
- Masp-2 inhibitors and methods of use9 Jul 2026US 2026/0193179 A9Omeros Corporation
- Sirtuin modulating compounds, including sirtuin activating compounds, and applications thereof23 Apr 2026US 2026/0109713 A1
- (2,4-dichlorophenoxy)acetic acid analogs12 Feb 2026US 2026/0042731 A1Corteva Agriscience LLC
- Masp-2 inhibitors and methods of use11 Dec 2025US 2025/0376443 A1Omeros Corporation
- Masp-2 inhibitors and methods of use4 Dec 2025US 2025/0368604 A1Omeros Corporation
Most cited
By later US patents
- Benzamides and related inhibitors of factor Xa115US 6,376,515 B2COR Therapeutics, Inc. · 2002
- Meta-substituted phenylene derivatives72US 5,773,646 AG. D. Searle & Co. · 1998
- Benzamidoxime derivatives, intermediates and processes for their preparation, and their use as fungicides69US 6,509,501 B2BASF SE · 2003
- Benzamides and related inhibitors of factor Xa66US 6,835,739 B2Millennium Pharmaceuticals, Inc. · 2004
- Substituted n-[(aminoiminomethyl or aminomethyl)phenyl]propyl amides59US 6,080,767 AAventis Pharmaceuticals Products Inc. · 2000